127 related articles for article (PubMed ID: 36542978)
1. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy.
Yang L; Wang Z; Gong H; Gai S; Shen R
J Colloid Interface Sci; 2023 Mar; 634():495-508. PubMed ID: 36542978
[TBL] [Abstract][Full Text] [Related]
2. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.
Hao Y; Gao Y; Fan Y; Zhang C; Zhan M; Cao X; Shi X; Guo R
J Nanobiotechnology; 2022 Jan; 20(1):43. PubMed ID: 35062953
[TBL] [Abstract][Full Text] [Related]
3. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
[TBL] [Abstract][Full Text] [Related]
5. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract][Full Text] [Related]
6. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
[TBL] [Abstract][Full Text] [Related]
7. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
[TBL] [Abstract][Full Text] [Related]
8. GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy.
Liu C; Jia S; Tu L; Yang P; Wang Y; Ke S; Shi W; Ye S
ACS Biomater Sci Eng; 2022 May; 8(5):1942-1955. PubMed ID: 35357802
[TBL] [Abstract][Full Text] [Related]
9. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
[TBL] [Abstract][Full Text] [Related]
10. Self-accelerating H
Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
[No Abstract] [Full Text] [Related]
11. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
[TBL] [Abstract][Full Text] [Related]
13. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
[TBL] [Abstract][Full Text] [Related]
15. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
[TBL] [Abstract][Full Text] [Related]
17. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer.
Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z
J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964
[TBL] [Abstract][Full Text] [Related]
19. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
20. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]